Researchers at Universität Leipzig have identified a key “bone switch” called GPR133 that plays a major role in maintaining bone strength. By activating it with a compound known as AP503, scientists were able to increase bone density and reverse osteoporosis-like damage in mice. The findings suggest a new type of treatment that could not only prevent bone loss but also rebuild weakened bones, offering hope for people at risk of osteoporosis—especially with aging.
